Invention Grant
- Patent Title: Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
-
Application No.: US18174832Application Date: 2023-02-27
-
Publication No.: US12024523B2Publication Date: 2024-07-02
- Inventor: Johan Olof Broddefalk , Hans Fredrik Emtenâs , Kenneth Lars Granberg , Malin Anita Lemurell , Daniel Tor Pettersen , Alleyn Thomas Plowright , Lars Johan Andreas Ulander
- Applicant: AstraZeneca AB
- Applicant Address: SE Södertälje
- Assignee: ASTRAZENECA AB
- Current Assignee: ASTRAZENECA AB
- Current Assignee Address: SE Södertälje
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/4155 ; A61K31/4985 ; A61P9/00 ; A61P9/10 ; A61P11/00 ; C07D231/40 ; C07D231/44 ; C07D231/50 ; C07D413/12 ; C07D417/12 ; C07D498/04
Abstract:
The present application relates to novel compounds of formula (I)
to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.
to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.
Public/Granted literature
- US20230219967A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS Public/Granted day:2023-07-13
Information query
